Posted: Tuesday, November 11, 2008, 2:17 p.m., ESTnewslineA new study conducted by TR BioSurgical LLC of Chandler, Ariz., indicates that its TR Matrix is equal or superior to autologous bone grafting in clinical and radiographic scoring and may be a viable alternative to bone grafting procedures, according to the company. The study compared the use of TR Matrix, an osteopromotive bioscaffold, to autologous cancellous bone graft for osteotomy repair associated with the Tibial Tuberosity Advancement (TTA) surgery. “The ultimate goals of cranial cruciate ligament repair in dogs are rapid recovery time and a return to near normal structure and function,” said Jeff Kellerman, DVM, vice president of research and development at the company. “In order for the Tibial Plateau Leveling Osteotomy and TTA procedures to achieve these goals, they require cutting of healthy bone in the patient, referred to as an osteotomy. Application of TR Matrix is a critical step in achieving rapid and unimpaired healing of these osteotomy sites thereby accomplishing key goals in cruciate ligament repair and surgical outcome.” In related news, as part of a new multi-million dollar manufacturing, supply and distribution agreement, Healionics will provide its STAR biomaterial scaffold for TR BioSurgical’s TR-ClarifEYE, an implant for the treatment of glaucoma in animals. It is planned for limited market launch in the first quarter of 2009. “We are pleased that within two years of launching, our STAR will be used in its first commercial product for helping pets, and we look forward to working with [TR BioSurgical] on additional veterinary ophthalmic device applications,” said Michel Alvarez, chief operating officer and vice president of Business Development of Healionics. “The application of STAR in ophthalmic device implants for humans is our next area of focus as it represents a significantly larger market opportunity.” STAR (Sphere Templated Angiogenic Regeneration) is a biomaterial scaffold designed to enhance bio-integration and promote healing of implanted medical devices. Healionics is based in Redmond, Wash. <HOME>A new study conducted by TR BioSurgical LLC of Chandler, Ariz., indicates that its TR Matrix is equal or superior to autologous bone grafting in clinical and radiographic scoring and may be a viable alternative to bone grafting procedures, according to the company.A new study conducted by TR BioSurgical LLC of Chandler, Ariz., indicates that its TR Matrix is equal or superior to autologous bone grafting in clinical and radiographic scoring and may be a viable alternative to bone grafting procedures, according to the company.Study May Pave Way to Alternative Bone Grafting ProceduresStudy May Pave Way to Alternative Bone Grafting ProceduresTR BioSurgical LLC, TR Matrix, Sphere Templated Angiogenic Regeneration, STAR, Healionics
